Share the Video:

The state of the psychedelic sector

Josh Hardman

This talk aims to provide a rapid introduction to the state of the nascent psychedelic sector, fertilising the ground for more substantive discussions on this track. Helped along by data visualisations, Hardman surveys the financial, research and policy contexts in which psychedelic businesses are embedded; and, increasingly, are shaping. The talk finishes by reviewing a number of open questions surrounding the future of the psychedelic sector, from its unfolding clinical evidence base to its commercial viability.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

Patents, commons, and innovation in psychedelic drug development

Universities and companies are claiming intellectual property on psychedelic compounds, sparking dialogue on how patents may impact innovation and access to care in the psychedelic ecosystem. Explore economic and cultural

Jonathan Sporn, Sisi Li, Graham Pechenik, Retsina Meyer, Anne Donohoe

PS2023 Business Health Equity Policy and Advocacy Psychedelic Science Research Research and Science

Innovations in Global Healthcare and Lessons for Psychedelics

Elliot Cohen (Pillpack, Amazon) and Protik Basu (World Bank, UN, Helena) share insights on healthcare delivery, psychedelics industry, scaling challenges, and technology's role in patient care.

Andrew “Mo” Septimus, Protik Basu, Elliot Cohen

PS2023 Business Policy and Advocacy Psychedelic Science Research Research and Science

Regulatory considerations and opportunities

Panel on regulatory obstacles in psychedelic therapy research: Leaders from the industry discuss challenges with policymakers and predict future developments in the field.

Tadeusz Hawrot, Natasia Poinsatte, Nicole Howell

PS2023 Policy Policy and Advocacy Psychedelic Science Research Research and Science Social and Cultural

Psychedelic policy approaches: from the visionary to the pragmatic

Discussion between experts on pragmatic frameworks, demographic considerations, and evidence-based practices shaping psychedelic policy reform for diverse contexts, addressing regulatory challenges and fostering nuanced understanding.

Tatiana Quintana, Melissa Lavasani, Logan Davidson

PS2023 Policy Policy and Advocacy Psychedelic Science Public Benefit Research Research and Science

Updates from leading statewide regulatory initiatives - Oregon

Oregon’s Psilocybin Services Act and Colorado’s Natural Medicine Health Act are pioneering successful statewide initiatives regulating adult psychedelic substance use, influencing drug policy reforms in eleven other states in 2023.

Angela E Albee, Sam Chapman

PS2023 MDMA Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

Priorities for the next generation of psychedelic science

NIMH Director Joshua A. Gordon and trauma researcher Barbara O. Rothbaum discuss the current state and future directions of psychedelic research, emphasizing the need for deeper understanding and robust study

Joshua A Gordon

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Public Benefit Research Research and Science

What Will People Think? Revealing Public Knowledge, Belief, and Perceptions of Psychedelics

Imran Khan presents findings of the Psychedelic Insight Poll, a national survey by the Berkeley Center for the Science of Psychedelics to understand public perceptions of psychedelic substances. The poll

Imran Khan

PS2023 Policy and Advocacy Psychedelic Science Research Research and Science

A conversation with Carl Hart, Ph.D.

Carl Hart, Chair of Psychology at Columbia University, is a renowned neuropsychopharmacologist, author, and media personality known for challenging drug perceptions through research, books, and media appearances.

Carl Hart

PS2023 Policy and Advocacy Psychedelic Assisted Therapy Psychedelic Science Research Research and Science Resources for Therapists

The State of Psychedelic Research Since 2017

Drs. Summergrad and Insel reflect on the progress and remaining questions in psychedelic science since 2017. They delve into topics like efficacy, regulation, therapy, and provider experience.

Paul Summergrad, Tom Insel, Rachel Nuwer

The state of the psychedelic sector

Become a MAPS Member with a monthly donation

Related Videos